Poor outcomes after whole brain radiotherapy in patients with brain metastases: Results from an international multicentre cohort study

Clinical Oncology

Volumn 25, Issue 11, 2013, Pages 674-680

  Windsor, A A ^a,b   Koh, E S ^a,b   Allen, S ^a,b   Gabriel, G S ^a,b   Yeo, A E T ^c   Allison, R ^d   van der Linden, Y M ^e   Barton, M B ^a,b  

^a LIVERPOOL HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c INGHAM INSTITUTE FOR APPLIED MEDICAL RESEARCH   (Australia)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^e Radiotherapeutic Institute Friesland   (Netherlands)

Author keywords

Brain; Neoplasm; Neoplasm metastasis; Outcomes; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN METASTASIS; BREAST CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; COLORECTAL CANCER; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL;

BRAIN; NEOPLASM; NEOPLASM METASTASIS; OUTCOMES; RADIOTHERAPY;

ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; BRAIN NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84884815066     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2013.07.002     Document Type: Article

References (28)

1. Gaspar L., Scott C., Rotman M., et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997, 37(4):745-751.
2. Sperduto P.W., Berkey B., Gaspar L.E., Mehta M., Curran W. Anew prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 2008, 70(2):510-514.
3. Sperduto C.M., Watanabe Y., Mullan J., et al. Avalidation study of a new prognostic index for patients with brain metastases: the Graded Prognostic Assessment. JNeurosurg 2008, 109(Suppl.):87-89.
4. Lagerwaard F.J., Levendag P.C., Nowak P.J., Eijkenboom W.M., Hanssens P.E., Schmitz P.I. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 1999, 43(4):795-803.
5. Rades D., Dunst J., Schild S.E. Anew scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases. Strahlenther Onkol 2008, 184(5).
6. Nieder C., Pawinski A., Molls M. Prediction of short survival in patients with brain metastases based on three different scores: a role for 'triple-negative' status?. Clin Oncol (R Coll Radiol) 2010, 22(1):65-69.
7. Ammirati M., Cobbs C.S., Linskey M.E., et al. The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline. JNeurooncol 2010, 96(1):85-96.
8. Bahl A., Kumar M., Sharma D.N., et al. Reirradiation for progressive brain metastases. JCancer Res Ther 2009, 5(3):161-164.
9. Sadikov E., Bezjak A., Yi Q.L., et al. Value of whole brain re-irradiation for brain metastases - single centre experience. Clin Oncol (R Coll Radiol) 2007, 19(7):532-538.
10. Wong W.W., Schild S.E., Sawyer T.E., Shaw E.G. Analysis of outcome in patients reirradiated for brain metastases. Int J Radiat Oncol Biol Phys 1996, 34(3):585-590.
11. Weltman E., Salvajoli J.V., Brandt R.A., et al. Radiosurgery for brain metastases: a score index for predicting prognosis. Int J Radiat Oncol Biol Phys 2000, 46(5):1155-1161.
12. Bezjak A., Adam J., Barton R., et al. Symptom response after palliative radiotherapy for patients with brain metastases. Eur J Cancer 2002, 38(4):487-496.
13. Sundaresan P., Yeghiaian-Alvandi R., Gebski V. Prognostic index to identify patients who may not benefit from whole brain radiotherapy for multiple brain metastases from lung cancer. JMed Imaging Radiat Oncol 2010, 54(1):69-75.
14. Cramb S.M., Baade P.D. Atlas of Cancer in Queensland: geographical variation in incidence and survival, 1998 to 2007 2011, Centre for Research in Cancer Control, Cancer Council Queensland, Brisbane.
15. Barton M.B., Hudson H.M., Delaney G., Gruver P., Liu Z. Patterns of retreatment by radiotherapy. Clin Oncol (R Coll Radiol) 2011, 23(1):10-18.
16. IBM SPSS Statistics for Windows, Version 21.0 2012, SPSS, Statistical Package for the Social Sciences, IBM Corp. Released, IBM Corp, Armonk, NY.
17. ArcGIS Desktop: Release 10.1 2012, ESRI, Environmental Systems Research Institute, Redlands, CA.
18. Sundstrom J.T., Minn H., Lertola K.K., Nordman E. Prognosis of patients treated for intracranial metastases with whole-brain irradiation. Ann Med 1998, 30(3):296-299.
19. Craighead P.S., Chan A. Defining treatment for brain metastases patients: nihilism versus optimism. Support Care Cancer 2012, 20(2):279-285.
20. Agarwal J.P., Wadasadawala T., Munshi A., et al. Validation of recursive partitioning analysis classification in patients with brain metastases from non-small cell lung cancer treated with short-course accelerated radiotherapy. Clin Oncol (R Coll Radiol) 2010, 22(10):837-843.
21. Bajard A., Westeel V., Dubiez A., et al. Multivariate analysis of factors predictive of brain metastases in localised non-small cell lung carcinoma. Lung Cancer 2004, 45(3):317-323.
22. Gulbas H., Erkal H.S., Serin M. The use of recursive partitioning analysis grouping in patients with brain metastases from non-small-cell lung cancer. Jpn J Clin Oncol 2006, 36(4):193-196.
23. Sperduto P.W., Chao S.T., Sneed P.K., et al. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 2010, 77(3):655-661.
24. Eigentler T.K., Figl A., Krex D., et al. Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma. Cancer 2011, 117(8):1697-1703.
25. Zakrzewski J., Geraghty L.N., Rose A.E., et al. Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival. Cancer 2011, 117(8):1711-1720.
26. Anders C.K., Deal A.M., Miller C.R., et al. The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases. Cancer 2011, 117(8):1602-1611.
27. Chow E., Davis L., Holden L., Tsao M., Danjoux C. Prospective assessment of patient-rated symptoms following whole brain radiotherapy for brain metastases. JPain Symptom Manage 2005, 30(1):18-23.
28. Langley R.E., Stephens R.J., Nankivell M., et al. Interim data from the Medical Research Council QUARTZ trial: does whole brain radiotherapy affect the survival and quality of life of patients with brain metastases from non-small cell lung cancer?. Clin Oncol (R Coll Radiol) 2013, 25(3):23-30.